Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
about
Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activityPathogenesis of thrombotic microangiopathiesHemolytic uremic syndrome following the infusion of oxaliplatin: case report.Thrombotic thrombocytopenic purpura associated with abacavir in a patient with HIV infection.Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review.Von Willebrand factor-cleaving protease activity remains at the intermediate level in thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura associated with quetiapine.Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities.Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation.Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy.Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpuraDrug-induced hematologic syndromes[Thrombotic microangiopathy after extracorporeal circulation: important differential diagnosis].Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.Investigational drugs in thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura after prophylactic cefuroxime axetil administered in relation to a liposuction procedure.Atypical thrombotic thrombocytopenic purpura in a middle-aged woman who presented with a recurrent stroke.Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosusCyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature.End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.ADAMTS13 deficiency and thrombotic thrombocytopenic purpura associated with trimethoprim-sulfamethoxazoleAcquired thrombotic thrombocytopenic purpura in children: a single institution experience.Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim.Fatal hemolytic uremic syndrome associated with day care surgery and anaesthesia: a case report.Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.Postoperative thrombotic thrombocytopenic purpura.Fatal quinine-induced thrombocytopenia from pulmonary haemorrhage.Hemolytic uremic syndrome associated with paraquat intoxication.Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1aCiprofloxacin-Induced Thrombotic Thrombocytopenic Purpura: A Case of Successful Treatment and Review of the Literature.Plasma exchange in Immunoglobulin A nephropathy with thrombotic microangiopathy and acute cortical necrosis.Thrombotic Thrombocytopenic Purpura: Pathogenesis, Diagnosis, and Potential Novel Therapeutics.38-Year-old woman with increasing fatigue and dyspneaProtein phosphatase 2B inhibition promotes the secretion of von Willebrand factor from endothelial cells.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Drug-associated renal dysfunction and injury.Nephrotoxicity of recent anti-cancer agents.A patient with acquired hemophilia A induced by clopidogrel.
P2860
Q24535720-40107089-B686-4916-B14E-95BF304A7CE4Q24658043-F2037DBF-A037-41F6-92C1-3A2E9591E13FQ33257302-7F16A944-DF0E-4AB0-B67B-185E1F245557Q33359746-62D260B8-0A88-4E03-90AB-15F5377CB8BAQ33360049-390D2D29-E977-4192-B495-573FBB7621A7Q33361713-30285D05-57AD-4A9A-8CE5-4DDE2E54924DQ33366113-FEF26F87-ED8E-4A30-8B29-54BABE3D4642Q33366475-49D892B0-D792-4EC6-BF86-D33A1A7E4506Q33369194-79E20FF1-19E8-451A-BB44-8881F6DF4533Q33371596-73A3315E-A99C-4684-8253-DAE022C96F51Q33374294-96F55237-F1E3-48FE-924D-2C296578D906Q33375632-80285E32-FC34-45EE-9474-B11FD144D5EAQ33381314-2C74CC26-D32B-4AA7-A217-0C0D9C793570Q33387312-C4951F01-AF08-43BF-9262-1EC839DB844BQ33393404-940C4054-B046-4F29-9104-C297173678B2Q33394558-21A2639E-B5F8-4BEA-A9CF-6D20926248F5Q33395696-1D531D8F-CFAA-4D32-A83F-CE499E90906AQ33396779-4F17524B-4DE3-4E3E-903F-AE48FE285622Q33401469-67AB6A34-90AF-4E26-9A0B-9EBAC8F5531EQ33403301-9782BB7C-333C-48AD-9AC9-6E7CDD7256E9Q33404199-8929BE3F-730C-493A-AA05-BCD028C771DBQ33404656-956539FD-E01D-4271-A4F0-6C8B596DFB64Q33404941-03055DB9-CA3F-4B85-B9E8-BBF01842822DQ33404950-91F39FE2-7D34-469B-8755-EBDBC04927E6Q33406819-166CCB57-29F2-435B-A41C-D3BC2FBC1F1EQ33408687-725A1EA1-C94F-43E5-8066-9DE652CB9C53Q33409827-FA3000DC-F3A1-475E-9C8E-096057546029Q33412350-EEC712A8-9B6A-4641-A90C-DDBCD8F830A0Q33414788-A22706E6-C700-4673-B76B-8F9D6EDB13F6Q33416236-F23DB218-7116-4693-B76A-08D43C6C57FEQ33422969-CC338580-DA57-4C63-B1A7-571B1BEA6721Q33427695-0DCC3A9C-D6D9-4723-ADB9-FE4F76A0F281Q33430469-048344D0-028A-4CE8-99B1-2C431AF8F256Q33443111-08306C98-6691-4992-9E38-C2E092AAEFEDQ33765085-0D2FD7FF-BD44-4D89-97C4-8B39CC5E4669Q33787391-70232E93-6708-4478-A3FA-D517BE35FF01Q34122035-3F0E80BA-6055-4E5F-A094-69CD16D5642CQ34560483-6177DAF5-2EE2-47D7-A3E7-DDA3019E9A47Q35310741-3716637A-DC7D-417B-A659-0298F58CF44AQ35865603-8BEB12F2-266A-44E1-BADD-EF2CC37C9F56
P2860
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@ast
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@en
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@nl
type
label
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@ast
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@en
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@nl
prefLabel
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@ast
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@en
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@nl
P2093
P1476
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
@en
P2093
P304
P356
10.1097/00062752-200109000-00004
P577
2001-09-01T00:00:00Z